COVID-19
  • Article
  • Jul 8 2020

CCTS is partnering with NCATS, the National Center for Data to Health, and around 60 other clinical institutions affiliated with the NCATS Clinical and Translational Science Awards Program to leverage big data in the fight against COVID-19.

  • Article
  • Jun 25 2020

The new potential treatment has been added to the University of Kentucky’s innovative clinical trial for experimental COVID-19 therapies, which was launched by leaders from UK’s Markey Cancer Center, College of Medicine and College of Pharmacy in May.

  • Article
  • Jun 22 2020

UK announced a research collaboration with Atomwise, an industry leader in using artificial intelligence (AI) for small molecule discovery, to explore potential COVID-19 therapies.

  • Video
  • Jun 18 2020

UK College of Medicine researchers are using the special antibodies made by alpacas, called nanobodies, to help understand the novel coronavirus and potentially develop a treatment that could protect people from being infected. 

  • Article
  • Jun 17 2020

Known as Serologic Testing to Accelerate Recovery and Transition (START), the study focuses on antibody testing to begin understanding how many people in the region may have already contracted and recovered from COVID-19.

  • Article
  • Jun 12 2020

UK researchers across many disciplines are addressing COVID-19’s medical challenges and beyond — including developing new PPE materials, designing testing and diagnostic equipment, and examining the wider societal, economic and legal implications of the pandemic.

  • Article
  • Jun 11 2020

The study seeks to answer how sectors of local and regional food systems are responding to COVID-19, what successful adaptations have been implemented, what obstacles the various arms of local food systems have encountered and the economic and value-chain impacts.

  • Article
  • Jun 10 2020

Researchers at UK are exploring the use of an antiseptic nasal spray and gargle to prevent transmission and infection of the virus among healthcare workers and non-COVID patients.

  • Article
  • Jun 10 2020

A new pilot funding program for multidisciplinary COVID-19 research at the University of Kentucky has launched in record time and funded 12 pilot projects in as many weeks.

  • Video
  • Jun 9 2020

“The virus is about 120 nanometers in size — in the world of membranes, that's large. Even more so, it's not going to come as a virus by itself, flying in the air. It's going to come in the saliva, so it's going to be a much larger particle. A large particle is just not going through (this filter).”